Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, the latest drugmaker to boost its U.S. manufacturing amid President Donald Trump's tariff threats.

This expansion of our Durham plant is a crucial component of the more than $12 billion Merck has invested toward U.S. capital ...

Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, as the drugmaker seeks to boost its U.S ...

MSD has opened the doors of a $1 billion manufacturing facility at its site in Durham, North Carolina, that will be used to produce the bulk drug substance for its HPV vaccine Gardasil.

Merck opens new, $1 billion, 225,000-sq ft facility dedicated to vaccine manufacturing at its Durham, North Carolina, site: Durham, North Carolina Wednesday, March 12, 2025, 09:00 ...

The contract biotech company plans to invest around $50 million to buy and renovate a Baltimore facility as it shifts more ...

Merck & Co. (MSD outside the U.S. and Canada) has just unveiled a brand-new, cutting-edge vaccine manufacturing facility at ...

Trump’s demand for firms to relocate to the US could be a problem for Ireland as big pharma may be pushed to consider ...

Ahead of possible tit-for-tat measures, Eurostat has published figures showing the EU exported €531.6 billion in goods to the ...